neurological conditions
Shared goals, shared knowledge: raising the profile of neurorehabilitation
The Independent Neurorehabilitation Providers’ Alliance (INPA) recently joined The Neurological Alliance. Chloë Hayward from INPA writes: INPA is a collation of independent organisations providing rehabilitation for people with acquired brain injuries, spinal cord injuries and neurological conditions. Some INPA members are large companies with multiple specialist units, others have one dedicated service. There are also […]
Unwavering focus: pushing for improvement in neurological services
Dr Arani Nitkunan, consultant neurologist and Neurological Alliance Trustee, writes: As a consultant neurologist working mainly in a district general hospital in Southwest London (Croydon University Hospital), there are several reasons why I very much appreciate all the work of The Neurological Alliance. Firstly, the Alliance’s surveys (including My Neuro Survey), have informed us that […]
Alliance Member Epilepsy Action campaigning for change
Alliance member Epilepsy Action shows how they are supporting the Alliance’s goals and placing the experiences of people with living with a neurological condition front and centre as they campaign for change. Daniel Jennings, Senior Policy and Campaigns Officer and Claudia Christie, Media Officer at Epilepsy Action, write: Since Personal Independence Payments (PIP) were introduced […]
Things have changed for the better. Is that the case for your neurological condition?
Sarah Joiner, Vice Chair of the MS Trust and member of The Neurological Alliance #MyNeuroSurvey Steering Group, writes: I was diagnosed with multiple sclerosis in 1981. Back then I received care from a consultant and a small medical team. Hours of waiting all morning, an examination to see how the condition had progressed, and some […]
Celebrating achievements across the neuro community
As we publish our annual report, we reflect on the Alliance’s activities in the last financial year (July 2020 – June 2021), celebrate achievements from across the neurological community, and look to the future.
Government announces £375 million investment in neurodegenerative conditions research
On Sunday (14th November) the government announced £375 million of investment over the next five years to fund projects to improve our understanding and treatment of a range of neurodegenerative conditions, including Motor Neurone Disease (MND), Parkinson’s disease dementia and Lewy’s Body dementia. The announcement comes after the success of the United to End MND […]
